Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mentor breast implant trial amended

This article was originally published in The Gray Sheet

Executive Summary

FDA approves a protocol change May 2 to the firm's 10-year post-approval study for its Memory Gel silicone-filled breast implants to allow patients to receive the implants even if they do not participate in the study. Access to Memory Gel will continue to be available only through physicians participating in the study (1"The Gray Sheet" Nov. 27, 2006, p. 3). Mentor says it has enrolled close to 4,000 patients in the 40,000-patient study since the implants' conditional approval in November...
Advertisement

Related Content

Sales Of Silicone Breast Implants To Easily Offset Post-Approval Study Costs
Sales Of Silicone Breast Implants To Easily Offset Post-Approval Study Costs
Advertisement
UsernamePublicRestriction

Register

MT024771

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel